Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Basic): 2022-2025

Historic EPS (Basic) for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$3.36.

  • Praxis Precision Medicines' EPS (Basic) fell 22.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 39.50%. This contributed to the annual value of -$10.21 for FY2024, which is 45.37% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' EPS (Basic) stood at -$3.36, which was down 1.51% from -$3.31 recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' EPS (Basic) registered a high of -$0.96 during Q3 2022, and its lowest value of -$65.86 during Q4 2022.
  • Over the past 3 years, Praxis Precision Medicines' median EPS (Basic) value was -$3.00 (recorded in 2024), while the average stood at -$3.90.
  • Over the last 5 years, Praxis Precision Medicines' EPS (Basic) had its largest YoY gain of 97.02% in 2023, and its largest YoY loss of 600.66% in 2023.
  • Praxis Precision Medicines' EPS (Basic) (Quarterly) stood at -$65.86 in 2022, then soared by 97.02% to -$1.96 in 2023, then crashed by 53.06% to -$3.00 in 2024, then fell by 22.18% to -$3.36 in 2025.
  • Its EPS (Basic) was -$3.36 in Q3 2025, compared to -$3.31 in Q2 2025 and -$3.29 in Q1 2025.